BSE Live
Apr 06, 16:01Prev. Close
333.35
Open Price
328.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Apr 06, 15:52Prev. Close
333.25
Open Price
331.20
Bid Price (Qty.)
336.90 (1086)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of FDC (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 14.34 | 9.84 | 9.47 | 10.52 | 8.82 | |
| Diluted EPS (Rs.) | 14.34 | 9.84 | 9.47 | 10.52 | 8.82 | |
| Cash EPS (Rs.) | 16.62 | 11.68 | 11.61 | 12.41 | 10.66 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 90.18 | 81.80 | 72.06 | 70.75 | 58.45 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 90.18 | 81.80 | 72.06 | 70.75 | 58.45 | |
| Dividend / Share(Rs.) | 0.80 | 0.00 | 0.00 | 2.25 | 2.25 | |
| Revenue from Operations/Share (Rs.) | 77.85 | 61.41 | 60.63 | 56.48 | 55.84 | |
| PBDIT/Share (Rs.) | 21.42 | 15.69 | 15.43 | 16.33 | 14.26 | |
| PBIT/Share (Rs.) | 19.24 | 13.80 | 13.43 | 14.39 | 12.38 | |
| PBT/Share (Rs.) | 19.04 | 13.49 | 13.35 | 13.98 | 12.30 | |
| Net Profit/Share (Rs.) | 14.43 | 9.79 | 9.61 | 10.47 | 8.78 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 27.51 | 25.54 | 25.45 | 28.90 | 25.53 | |
| PBIT Margin (%) | 24.70 | 22.46 | 22.15 | 25.48 | 22.16 | |
| PBT Margin (%) | 24.45 | 21.96 | 22.02 | 24.75 | 22.02 | |
| Net Profit Margin (%) | 18.53 | 15.94 | 15.84 | 18.54 | 15.72 | |
| Return on Networth / Equity (%) | 16.00 | 11.97 | 13.33 | 14.80 | 15.02 | |
| Return on Capital Employed (%) | 21.06 | 16.68 | 18.38 | 20.05 | 20.77 | |
| Return on Assets (%) | 13.66 | 10.55 | 11.32 | 12.81 | 12.78 | |
| Total Debt/Equity (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Asset Turnover Ratio (%) | 73.72 | 66.18 | 71.45 | 69.12 | 81.35 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.77 | 4.12 | 3.43 | 3.96 | 3.03 | |
| Quick Ratio (X) | 2.92 | 3.15 | 2.65 | 3.20 | 2.23 | |
| Inventory Turnover Ratio (X) | 6.35 | 6.23 | 6.65 | 7.41 | 7.66 | |
| Dividend Payout Ratio (NP) (%) | 5.55 | 0.00 | 28.61 | 0.00 | 25.51 | |
| Dividend Payout Ratio (CP) (%) | 4.82 | 0.00 | 23.68 | 0.00 | 21.01 | |
| Earnings Retention Ratio (%) | 94.45 | 0.00 | 71.39 | 0.00 | 74.49 | |
| Cash Earnings Retention Ratio (%) | 95.18 | 0.00 | 76.32 | 0.00 | 78.99 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 3,321.60 | 2,919.20 | 4,389.87 | 3,623.29 | 3,296.20 | |
| EV/Net Operating Revenue (X) | 2.50 | 2.71 | 4.13 | 3.59 | 3.30 | |
| EV/EBITDA (X) | 9.07 | 10.62 | 16.24 | 12.43 | 12.94 | |
| MarketCap/Net Operating Revenue (X) | 2.52 | 2.73 | 4.15 | 3.61 | 3.32 | |
| Retention Ratios (%) | 94.44 | 0.00 | 71.38 | 0.00 | 74.48 | |
| Price/BV (X) | 2.17 | 2.05 | 3.49 | 2.88 | 3.17 | |
| Price/Net Operating Revenue | 2.52 | 2.73 | 4.15 | 3.61 | 3.32 | |
| Earnings Yield | 0.07 | 0.06 | 0.04 | 0.05 | 0.05 |
10.02.2026
FDC Consolidated December 2025 Net Sales at Rs 464.71 crore, up 0.13% Y-o-Y
09.02.2026
FDC Standalone December 2025 Net Sales at Rs 457.94 crore, down 0.2% Y-o-Y
11.11.2025
FDC Standalone September 2025 Net Sales at Rs 461.74 crore, down 8.58% Y-o-Y
07.11.2025
FDC Consolidated September 2025 Net Sales at Rs 473.03 crore, down 7.94% Y-o-Y
10.02.2026
FDC Consolidated December 2025 Net Sales at Rs 464.71 crore, up 0.13% Y-o-Y
09.02.2026
FDC Standalone December 2025 Net Sales at Rs 457.94 crore, down 0.2% Y-o-Y
11.11.2025
FDC Standalone September 2025 Net Sales at Rs 461.74 crore, down 8.58% Y-o-Y
07.11.2025
FDC Consolidated September 2025 Net Sales at Rs 473.03 crore, down 7.94% Y-o-Y
06.04.2026
06.04.2026
02.04.2026
02.04.2026
Lupin shares down 2% as arm to acquire 43.38% stake in Multicare Pharma
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth